Results 11 to 20 of about 19,278,359 (237)

Anti-G with concomitant anti-C and anti-D: A case report in a pregnant woman

open access: yesAsian Journal of Transfusion Science, 2017
The G antigen of Rh blood group system is present in almost all D-positive or C-positive red cells but absent from red cells lacking D and C antigens. The differentiation of anti-D and anti-C from anti-G is not necessary for routine transfusion; however,
Rabeya Yousuf   +4 more
doaj   +2 more sources

Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

open access: yesBiologics: Targets & Therapy, 2009
Eric Cheung, Howard A LiebmanJane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California-Keck School of Medicine, Los Angeles, CA, USAAbstract: Immune thrombocytopenia (ITP) is an acquired bleeding ...
Eric Cheung, Howard A Liebman
doaj   +1 more source

Properties of Heterologous anti-Ebola Immunoglobulin after Long Storage [PDF]

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2020
Ebola outbreak in eastern parts of the Democratic Republic of the Congo in 2018–2020 proved that the virus remains highly hazardous for humans, and the outbreak in West Africa in 2014–2016, which was the largest Ebola outbreak in history, showed that it ...
S. A. Melnikov   +15 more
doaj   +2 more sources

Sequence analysis of variable regions of human monoclonal anti-P immunoglobulin

open access: yesZhongguo shuxue zazhi
[Objective] To identify the structure of the complementarity determining region (CDRs), the V(D)J rearrangement and somatic hypermutational characteristics of the heavy and light chains of a red blood cell blood group-specific monoclonal antibody ...
GUO Zhonghui   +3 more
doaj   +2 more sources

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation [PDF]

open access: yes, 1993
We have constructed a soluble chimeric fusion protein between the mouse CD8 alpha chain and the mouse CD40 T cell ligand. This protein binds to both human and mouse B cells.
Lane, P.   +5 more
core   +2 more sources

Rhesus anti-D immunoglobulin in chronic autoimmune neuropathy

open access: yes, 1998
Objective - To investigate the effect of Rhesus anti-D immunoglobulin (anti-D) in patients with an autoimmune demyelinating neuropathy. Material and methods - Three patients with an autoimmune mediated neuropathy received 1000 IU anti-D weekly for 2 ...
de Jager, AEJ   +4 more
core   +2 more sources

Cancer as a Dysfunctional Immune Disorder: Pro-Tumor TH1-like Immune Response and Anti-Tumor THαβ Immune Response Based on the Complete Updated Framework of Host Immunological Pathways

open access: yesBiomedicines, 2022
Host immunological pathways are delicate to cope with different types of pathogens. In this article, we divide immunological pathways into two groups: Immunoglobulin G-related eradicable immunities and Immunoglobulin A-related tolerable immunities.
Yi-Hsin Lee   +4 more
doaj   +1 more source

Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report [PDF]

open access: yes, 2015
Background: Anti–N-methyl-D-aspartate receptor immunoglobulin G antibodies directed against the GluN1 subunit are considered highly specific for anti-N-methyl-D-aspartate receptor encephalitis, a severe clinical syndrome characterized by seizures ...
Anne Waschbisch   +13 more
core   +3 more sources

A successful pregnancy occurred after isolating the offending antibody(s) and choosing appropriate sperm donor of similar phenotype

open access: yesGlobal Journal of Transfusion Medicine, 2019
Sensitization against Rh(D )is the most common cause of haemolytic disease of fetus and newborn (HDFN). Now a days, a widespread use of antenatal and postnatal Rh immunoglobulin has resulted in marked decrease in prevalence of Rh(D) alloimmunization ...
Sourav Mukherjee   +4 more
doaj   +1 more source

THE USE OF ROMIPLOSTIM IN AN INFANT

open access: yesHematology, Transfusion and Cell Therapy, 2021
Case report: Immune thrombocytopenia (ITP) is the most common platelet disorder in children, peaking between the ages of 1-7.The first line therapy consists of intravenous immunoglobulin, anti-D immunoglobulin or corticosteroids.
Fatma Burçin KURTİPEK   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy